首页> 外国专利> METHOD OF STEM CELL DELIVERY INTO THE BRAIN DURING CHRONIC DISEASE USING BLOOD BRAIN BARRIER PERMEABILIZERS

METHOD OF STEM CELL DELIVERY INTO THE BRAIN DURING CHRONIC DISEASE USING BLOOD BRAIN BARRIER PERMEABILIZERS

机译:血脑屏障渗透剂使慢性干细胞在慢性疾病中进入干细胞的方法

摘要

Blood brain barrier (BBB) permeabilizers, such as mannitol, can facilitate the entry of stem cells from the periphery to the stroke brain. It is unknown whether BBB permeation in the chronic stage of the disease still facilitates the entry of stem cells from the periphery to the injured brain. Evidence herein shows BBB permeation in the chronic stage of stroke assisted in the entry of stem cells from the periphery to the stroke brain. Stroke models treated with human umbilical cord stem cells (hUCBC) only (2 million viable cells), mannitol or a combination. Results revealed that hUCBC alone or combined with mannitol displayed significant behavioral and histological deficits compared to control animals, with the HUCBC-mannitol combined treatment showing improvements over hUCBC only treatments in brain cell survival in the peri-infarct area. BBB permeation in chronic stroke also lowers the effective stem cell dose necessary to improve functional outcomes.
机译:血脑屏障(BBB)透化剂,例如甘露醇,可以促进干细胞从外周进入中风脑。尚不清楚该疾病慢性阶段的血脑屏障通透性是否仍能促进干细胞从外周进入受伤的大脑。本文的证据表明,在中风的慢性阶段,BBB渗透有助于干细胞从外周进入中风脑。仅使用人脐带干细胞(hUCBC)(200万个活细胞),甘露醇或二者结合治疗的中风模型。结果显示,与对照动物相比,单独的hUCBC或与甘露醇联合使用均表现出明显的行为和组织学缺陷,其中HUCBC-甘露醇联合治疗在梗死周围区域的脑细胞存活率方面优于仅hUCBC的治疗。慢性中风的BBB渗透也降低了改善功能结局所需的有效干细胞剂量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号